Improvement of Haemostasis Mediated by Anti-Platelet Activities by Plant Vinegar

목초액의 혈소판 응집억제를 통한 혈행개선 작용에 관한 연구

  • 김영대 (서울대학교 약학대학 종합약학연구소) ;
  • 배옥남 (서울대학교 약학대학 종합약학연구소) ;
  • 정승민 (서울대학교 약학대학 종합약학연구소) ;
  • 정진호 (서울대학교 약학대학 종합약학연구소)
  • Published : 2004.06.01

Abstract

We investigated the effects of plant vinegar on platelets and blood coagulation system. Plant vinegar inhibited in vitro platelet aggregation in a concentration dependent manner, when platelets were activated by thrombin and collagen. In addition, plant vinegar showed inhibitory effects on the serotonin secretion induced by thrombin in a concentration dependent manner. However, treatment with plant vinegar to platelets did not induce any cytotoxicity, as determined by the release of lactate dehydrogenase. Plant vinegar did not change the coagulation parameters such as activated partial thromboplastin time (aPTT) and prothrombin time (PT) using rat citrated plasma. In vivo study revealed that, treatment with plant vinegar prolonged the bleeding time from mouse tail. All these results suggest that plant vinegar might improve blood hemostasis mediated via anti platelet activities.

Keywords

References

  1. 김동희, 최주선, 김성훈 (2001a): 목초액과 항암성 본초가 가미된 복합목초액의 항암 및 항전이활성에 미치는 영향. 동의생리병리학회지, 15, 136-142
  2. 김동희, 최주선, 추지희, 송호철, 이은옥, 강인철, 최종원, 김성훈 (2001b): 참나무 목초액의 면역조절 작용과 항암효과에 관한 연구. 동의생리병리학회지, 15, 857-862
  3. 김판기, 왕성호, 김대용 (1997): Guh Sung Y.L.S.-95의 아급성 독성시험. J. Fd. Hyg. Safety, 12, 234-239
  4. De Glerck, F. and David, J.L. (1981): Pharmacological control of platelet and red blood cell function in the microcirculation. J. Cardiovasc. Pharmacol., 3, 1388-1412
  5. DiMinno, G. and Silver, M.J. (1983): Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J. Pharmacol. Exp. Ther., 225, 57-60
  6. Fanburg, B.L. and Lee, S.L. (1997): A new role for an old molecule: serotonin as a mitogen. Am. J. Physiol., 272, L795-L806
  7. FitzGerald, GA (1991): Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am. J. Cardiol., 68, 11B-15B
  8. Harker, L.A. (1994): Platelets and vascular thrombosis. N. Engl. J. Med., 330, 1006-1007 https://doi.org/10.1056/NEJM199404073301411
  9. Holmsen, H. and Dangelmaier, C.A. (1989): Measurement of secretion of serotonin. Methods Enzymol., 169, 205-210
  10. Macmahon, S. and Sharpe, N. (1991): Long-term antiplatelet therapy for the prevention of vascular disease. Med. J., 154, 477-480
  11. Matsuo, T., Koide, M. and Kario, K. (1997): Development of argatroban, a direct thrombin inhibitor, and its clinical application. Semin. Thromb. Hemost., 23, 517-522
  12. Murray, J.C., Kelly, M.A. and Gorlick, P.B. (1994): Ticlopidine: A new antiplatelet agent for the secondary prevention of stroke. Clin Neuropharmacol, 17, 23-31 https://doi.org/10.1097/00002826-199402000-00002
  13. Packham, M.A. (1994): Role of platelets in thrombosis and hemostasis. Can. J. Physiol. Pharmacol., 72, 278-284
  14. Ross, R. (1993): The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809 https://doi.org/10.1038/362801a0
  15. Stormorken, H. (1986): Platelets in hemostasis and thrombosis. In The Platelets: Physiology and Pharmacology (H. Holmsen, Ed.), pp. 3-32, CRC press, Florida